CIMCX
Price
$27.40
Change
+$0.08 (+0.29%)
Updated
Jun 2 closing price
Net Assets
146.54B
HRLRX
Price
$11.04
Change
+$0.05 (+0.45%)
Updated
Jun 2 closing price
Net Assets
67.76M
Interact to see
Advertisement

CIMCX vs HRLRX

Header iconCIMCX vs HRLRX Comparison
Open Charts CIMCX vs HRLRXBanner chart's image
CIMCX vs HRLRX Comparison Chart in %
View a ticker or compare two or three
VS
CIMCX vs. HRLRX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIMCX is a Buy and HRLRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIMCX has more cash in the bank: 147B vs. HRLRX (67.8M). HRLRX pays higher dividends than CIMCX: HRLRX (2.92) vs CIMCX (2.73). CIMCX was incepted earlier than HRLRX: CIMCX (24 years) vs HRLRX (16 years). HRLRX (2.01) is less costly to investors than CIMCX (1.35). HRLRX is a more actively managed with annual turnover of: 149.00 vs. CIMCX (65.00). HRLRX has a lower initial minimum investment than CIMCX: HRLRX (0) vs CIMCX (250). HRLRX annual gain was more profitable for investors over the last year : 23.66 vs. CIMCX (8.06). HRLRX return over 5 years is better than : 44.02 vs. CIMCX (20.12).
CIMCXHRLRXCIMCX / HRLRX
Total Expense Ratio1.351.5090%
Annual Report Gross Expense Ratio1.352.0167%
Fund Existence24 years16 years-
Gain YTD5.65413.18243%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets147B67.8M216,814%
Annual Yield % from dividends2.732.9293%
Returns for 1 year8.0623.6634%
Returns for 3 years33.0742.0079%
Returns for 5 years20.1244.0246%
Returns for 10 years67.7086.1579%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JLCAX23.77N/A
N/A
JPMorgan US Large Cap Core Plus A
OINCX25.45N/A
N/A
JPMorgan Equity Income C
PHSKX37.47N/A
N/A
Virtus KAR Mid-Cap Growth A
MXNSX22.96N/A
N/A
Empower S&P SmallCap 600® Index L
RYCFX45.37N/A
N/A
Rydex Biotechnology C